HEADER MEMBRANE PROTEIN 06-MAR-20 6Y9A TITLE STRUCTURE OF FULL-LENGTH CD20 IN COMPLEX WITH OBINUTUZUMAB FAB COMPND MOL_ID: 1; COMPND 2 MOLECULE: B-LYMPHOCYTE ANTIGEN CD20; COMPND 3 CHAIN: A, B; COMPND 4 SYNONYM: B-LYMPHOCYTE SURFACE ANTIGEN B1,BP35,LEUKOCYTE SURFACE COMPND 5 ANTIGEN LEU-16,MEMBRANE-SPANNING 4-DOMAINS SUBFAMILY A MEMBER 1; COMPND 6 ENGINEERED: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: OBINUTUZUMAB FAB HEAVY CHAIN; COMPND 9 CHAIN: H; COMPND 10 ENGINEERED: YES; COMPND 11 MOL_ID: 3; COMPND 12 MOLECULE: OBINUTUZUMAB FAB LIGHT CHAIN; COMPND 13 CHAIN: L; COMPND 14 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 CELL: B-LYMPHOCYTE; SOURCE 6 GENE: MS4A1, CD20; SOURCE 7 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 8 EXPRESSION_SYSTEM_COMMON: HUMAN; SOURCE 9 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 10 EXPRESSION_SYSTEM_CELL_LINE: HEK293F; SOURCE 11 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 12 EXPRESSION_SYSTEM_PLASMID: PCDNA3.1 +; SOURCE 13 MOL_ID: 2; SOURCE 14 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 15 ORGANISM_COMMON: HUMAN; SOURCE 16 ORGANISM_TAXID: 9606; SOURCE 17 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 18 EXPRESSION_SYSTEM_COMMON: HUMAN; SOURCE 19 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 20 EXPRESSION_SYSTEM_CELL_LINE: HEK293F; SOURCE 21 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 22 EXPRESSION_SYSTEM_PLASMID: IGG1 EXPRESSION VECTOR; SOURCE 23 MOL_ID: 3; SOURCE 24 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 25 ORGANISM_COMMON: HUMAN; SOURCE 26 ORGANISM_TAXID: 9606; SOURCE 27 EXPRESSION_SYSTEM: HOMO SAPIENS; SOURCE 28 EXPRESSION_SYSTEM_COMMON: HUMAN; SOURCE 29 EXPRESSION_SYSTEM_TAXID: 9606; SOURCE 30 EXPRESSION_SYSTEM_CELL_LINE: HEK293F; SOURCE 31 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 32 EXPRESSION_SYSTEM_PLASMID: IGG1 EXPRESSION VECTOR KEYWDS CANCER IMMUNOTHERAPY, THERAPEUTIC ANTIBODY, MEMBRANE PROTEIN EXPDTA ELECTRON MICROSCOPY AUTHOR A.KUMAR,N.REYES REVDAT 3 16-SEP-20 6Y9A 1 COMPND REVDAT 2 02-SEP-20 6Y9A 1 REMARK REVDAT 1 26-AUG-20 6Y9A 0 JRNL AUTH A.KUMAR,C.PLANCHAIS,R.FRONZES,H.MOUQUET,N.REYES JRNL TITL BINDING MECHANISMS OF THERAPEUTIC ANTIBODIES TO HUMAN CD20. JRNL REF SCIENCE V. 369 793 2020 JRNL REFN ESSN 1095-9203 JRNL PMID 32792392 JRNL DOI 10.1126/SCIENCE.ABB8008 REMARK 2 REMARK 2 RESOLUTION. 4.20 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 SOFTWARE PACKAGES : SERIALEM, GCTF, UCSF CHIMERA, COOT, REMARK 3 CRYOSPARC, CRYOSPARC, CRYOSPARC, REMARK 3 CRYOSPARC, PHENIX REMARK 3 RECONSTRUCTION SCHEMA : NULL REMARK 3 REMARK 3 EM MAP-MODEL FITTING AND REFINEMENT REMARK 3 PDB ENTRY : 3PP4 REMARK 3 REFINEMENT SPACE : REAL REMARK 3 REFINEMENT PROTOCOL : RIGID BODY FIT REMARK 3 REFINEMENT TARGET : NULL REMARK 3 OVERALL ANISOTROPIC B VALUE : NULL REMARK 3 REMARK 3 FITTING PROCEDURE : NULL REMARK 3 REMARK 3 EM IMAGE RECONSTRUCTION STATISTICS REMARK 3 NOMINAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 ACTUAL PIXEL SIZE (ANGSTROMS) : NULL REMARK 3 EFFECTIVE RESOLUTION (ANGSTROMS) : 4.200 REMARK 3 NUMBER OF PARTICLES : 63547 REMARK 3 CTF CORRECTION METHOD : PHASE FLIPPING AND AMPLITUDE REMARK 3 CORRECTION REMARK 3 REMARK 3 EM RECONSTRUCTION MAGNIFICATION CALIBRATION: NULL REMARK 3 REMARK 3 OTHER DETAILS: NULL REMARK 4 REMARK 4 6Y9A COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBE ON 09-MAR-20. REMARK 100 THE DEPOSITION ID IS D_1292107098. REMARK 245 REMARK 245 EXPERIMENTAL DETAILS REMARK 245 RECONSTRUCTION METHOD : SINGLE PARTICLE REMARK 245 SPECIMEN TYPE : NULL REMARK 245 REMARK 245 ELECTRON MICROSCOPE SAMPLE REMARK 245 SAMPLE TYPE : PARTICLE REMARK 245 PARTICLE TYPE : POINT REMARK 245 NAME OF SAMPLE : FULL-LENGTH HUMAN ANTIGEN CD20 REMARK 245 IN COMPLEX WITH OBINUTUZUMAB; REMARK 245 FULL-LENGTH HUMAN CD20; REMARK 245 OBINUTUZUMAB FAB REMARK 245 SAMPLE CONCENTRATION (MG ML-1) : 1.20 REMARK 245 SAMPLE SUPPORT DETAILS : NULL REMARK 245 SAMPLE VITRIFICATION DETAILS : GRIDS WERE BLOT FOR 3.5 SEC. REMARK 245 SAMPLE BUFFER : NULL REMARK 245 PH : 7.40 REMARK 245 SAMPLE DETAILS : NULL REMARK 245 REMARK 245 DATA ACQUISITION REMARK 245 DATE OF EXPERIMENT : NULL REMARK 245 NUMBER OF MICROGRAPHS-IMAGES : 10545 REMARK 245 TEMPERATURE (KELVIN) : NULL REMARK 245 MICROSCOPE MODEL : FEI TITAN KRIOS REMARK 245 DETECTOR TYPE : GATAN K2 SUMMIT (4K X 4K) REMARK 245 MINIMUM DEFOCUS (NM) : NULL REMARK 245 MAXIMUM DEFOCUS (NM) : NULL REMARK 245 MINIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 MAXIMUM TILT ANGLE (DEGREES) : NULL REMARK 245 NOMINAL CS : 2.70 REMARK 245 IMAGING MODE : BRIGHT FIELD REMARK 245 ELECTRON DOSE (ELECTRONS NM**-2) : 42.84 REMARK 245 ILLUMINATION MODE : FLOOD BEAM REMARK 245 NOMINAL MAGNIFICATION : NULL REMARK 245 CALIBRATED MAGNIFICATION : NULL REMARK 245 SOURCE : FIELD EMISSION GUN REMARK 245 ACCELERATION VOLTAGE (KV) : 300 REMARK 245 IMAGING DETAILS : NULL REMARK 247 REMARK 247 ELECTRON MICROSCOPY REMARK 247 THE COORDINATES IN THIS ENTRY WERE GENERATED FROM ELECTRON REMARK 247 MICROSCOPY DATA. PROTEIN DATA BANK CONVENTIONS REQUIRE REMARK 247 THAT CRYST1 AND SCALE RECORDS BE INCLUDED, BUT THE VALUES REMARK 247 ON THESE RECORDS ARE MEANINGLESS EXCEPT FOR THE CALCULATION REMARK 247 OF THE STRUCTURE FACTORS. REMARK 300 REMARK 300 BIOMOLECULE: 1 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TETRAMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TETRAMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 7590 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 41360 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -59.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, H, L REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 VAL H 217 CA CB CG1 CG2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 VAL A 82 -51.19 -126.40 REMARK 500 GLU A 105 27.35 43.23 REMARK 500 LYS A 110 -54.46 -129.12 REMARK 500 CYS A 167 76.21 -105.43 REMARK 500 ASN A 176 57.29 -99.39 REMARK 500 ALA B 102 34.42 -96.97 REMARK 500 LYS B 110 -21.64 -140.98 REMARK 500 CYS B 167 48.25 -92.47 REMARK 500 LYS H 12 -169.85 -126.29 REMARK 500 CYS H 22 56.97 -96.50 REMARK 500 ASP H 102 62.69 63.67 REMARK 500 SER H 119 53.59 -92.55 REMARK 500 SER H 136 47.70 -87.44 REMARK 500 ALA L 19 115.25 -160.34 REMARK 500 MET L 56 -9.56 72.84 REMARK 500 ASP L 87 49.46 -91.24 REMARK 500 REMARK 500 REMARK: NULL REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: MAIN CHAIN PLANARITY REMARK 500 REMARK 500 THE FOLLOWING RESIDUES HAVE A PSEUDO PLANARITY REMARK 500 TORSION ANGLE, C(I) - CA(I) - N(I+1) - O(I), GREATER REMARK 500 10.0 DEGREES. (M=MODEL NUMBER; RES=RESIDUE NAME; REMARK 500 C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 500 I=INSERTION CODE). REMARK 500 REMARK 500 M RES CSSEQI ANGLE REMARK 500 SER A 179 -10.13 REMARK 500 SER B 179 -11.42 REMARK 500 REMARK 500 REMARK: NULL REMARK 900 REMARK 900 RELATED ENTRIES REMARK 900 RELATED ID: EMD-10733 RELATED DB: EMDB REMARK 900 6Y97 SAME PROTEIN COMPLEX BUT FOCUSED REFINED REMARK 900 RELATED ID: EMD-10732 RELATED DB: EMDB REMARK 900 CD20 IN COMPLEX WITH OFATUMUMAB FAB REMARK 900 RELATED ID: EMD-10731 RELATED DB: EMDB REMARK 900 CD20 IN COMPLEX WITH RITUXIMAB REMARK 900 RELATED ID: EMD-10734 RELATED DB: EMDB REMARK 900 STRUCTURE OF FULL-LENGTH CD20 IN COMPLEX WITH OFATUMUMAB FAB DBREF 6Y9A A 45 213 UNP P11836 CD20_HUMAN 45 213 DBREF 6Y9A B 45 213 UNP P11836 CD20_HUMAN 45 213 DBREF 6Y9A H 2 220 PDB 6Y9A 6Y9A 2 220 DBREF 6Y9A L 1 219 PDB 6Y9A 6Y9A 1 219 SEQRES 1 A 169 PHE MET ARG GLU SER LYS THR LEU GLY ALA VAL GLN ILE SEQRES 2 A 169 MET ASN GLY LEU PHE HIS ILE ALA LEU GLY GLY LEU LEU SEQRES 3 A 169 MET ILE PRO ALA GLY ILE TYR ALA PRO ILE CYS VAL THR SEQRES 4 A 169 VAL TRP TYR PRO LEU TRP GLY GLY ILE MET TYR ILE ILE SEQRES 5 A 169 SER GLY SER LEU LEU ALA ALA THR GLU LYS ASN SER ARG SEQRES 6 A 169 LYS CYS LEU VAL LYS GLY LYS MET ILE MET ASN SER LEU SEQRES 7 A 169 SER LEU PHE ALA ALA ILE SER GLY MET ILE LEU SER ILE SEQRES 8 A 169 MET ASP ILE LEU ASN ILE LYS ILE SER HIS PHE LEU LYS SEQRES 9 A 169 MET GLU SER LEU ASN PHE ILE ARG ALA HIS THR PRO TYR SEQRES 10 A 169 ILE ASN ILE TYR ASN CYS GLU PRO ALA ASN PRO SER GLU SEQRES 11 A 169 LYS ASN SER PRO SER THR GLN TYR CYS TYR SER ILE GLN SEQRES 12 A 169 SER LEU PHE LEU GLY ILE LEU SER VAL MET LEU ILE PHE SEQRES 13 A 169 ALA PHE PHE GLN GLU LEU VAL ILE ALA GLY ILE VAL GLU SEQRES 1 B 169 PHE MET ARG GLU SER LYS THR LEU GLY ALA VAL GLN ILE SEQRES 2 B 169 MET ASN GLY LEU PHE HIS ILE ALA LEU GLY GLY LEU LEU SEQRES 3 B 169 MET ILE PRO ALA GLY ILE TYR ALA PRO ILE CYS VAL THR SEQRES 4 B 169 VAL TRP TYR PRO LEU TRP GLY GLY ILE MET TYR ILE ILE SEQRES 5 B 169 SER GLY SER LEU LEU ALA ALA THR GLU LYS ASN SER ARG SEQRES 6 B 169 LYS CYS LEU VAL LYS GLY LYS MET ILE MET ASN SER LEU SEQRES 7 B 169 SER LEU PHE ALA ALA ILE SER GLY MET ILE LEU SER ILE SEQRES 8 B 169 MET ASP ILE LEU ASN ILE LYS ILE SER HIS PHE LEU LYS SEQRES 9 B 169 MET GLU SER LEU ASN PHE ILE ARG ALA HIS THR PRO TYR SEQRES 10 B 169 ILE ASN ILE TYR ASN CYS GLU PRO ALA ASN PRO SER GLU SEQRES 11 B 169 LYS ASN SER PRO SER THR GLN TYR CYS TYR SER ILE GLN SEQRES 12 B 169 SER LEU PHE LEU GLY ILE LEU SER VAL MET LEU ILE PHE SEQRES 13 B 169 ALA PHE PHE GLN GLU LEU VAL ILE ALA GLY ILE VAL GLU SEQRES 1 H 219 VAL GLN LEU VAL GLN SER GLY ALA GLU VAL LYS LYS PRO SEQRES 2 H 219 GLY SER SER VAL LYS VAL SER CYS LYS ALA SER GLY TYR SEQRES 3 H 219 ALA PHE SER TYR SER TRP ILE ASN TRP VAL ARG GLN ALA SEQRES 4 H 219 PRO GLY GLN GLY LEU GLU TRP MET GLY ARG ILE PHE PRO SEQRES 5 H 219 GLY ASP GLY ASP THR ASP TYR ASN GLY LYS PHE LYS GLY SEQRES 6 H 219 ARG VAL THR ILE THR ALA ASP LYS SER THR SER THR ALA SEQRES 7 H 219 TYR MET GLU LEU SER SER LEU ARG SER GLU ASP THR ALA SEQRES 8 H 219 VAL TYR TYR CYS ALA ARG ASN VAL PHE ASP GLY TYR TRP SEQRES 9 H 219 LEU VAL TYR TRP GLY GLN GLY THR LEU VAL THR VAL SER SEQRES 10 H 219 SER ALA SER THR LYS GLY PRO SER VAL PHE PRO LEU ALA SEQRES 11 H 219 PRO SER SER LYS SER THR SER GLY GLY THR ALA ALA LEU SEQRES 12 H 219 GLY CYS LEU VAL LYS ASP TYR PHE PRO GLU PRO VAL THR SEQRES 13 H 219 VAL SER TRP ASN SER GLY ALA LEU THR SER GLY VAL HIS SEQRES 14 H 219 THR PHE PRO ALA VAL LEU GLN SER SER GLY LEU TYR SER SEQRES 15 H 219 LEU SER SER VAL VAL THR VAL PRO SER SER SER LEU GLY SEQRES 16 H 219 THR GLN THR TYR ILE CYS ASN VAL ASN HIS LYS PRO SER SEQRES 17 H 219 ASN THR LYS VAL ASP LYS LYS VAL GLU PRO LYS SEQRES 1 L 219 ASP ILE VAL MET THR GLN THR PRO LEU SER LEU PRO VAL SEQRES 2 L 219 THR PRO GLY GLU PRO ALA SER ILE SER CYS ARG SER SER SEQRES 3 L 219 LYS SER LEU LEU HIS SER ASN GLY ILE THR TYR LEU TYR SEQRES 4 L 219 TRP TYR LEU GLN LYS PRO GLY GLN SER PRO GLN LEU LEU SEQRES 5 L 219 ILE TYR GLN MET SER ASN LEU VAL SER GLY VAL PRO ASP SEQRES 6 L 219 ARG PHE SER GLY SER GLY SER GLY THR ASP PHE THR LEU SEQRES 7 L 219 LYS ILE SER ARG VAL GLU ALA GLU ASP VAL GLY VAL TYR SEQRES 8 L 219 TYR CYS ALA GLN ASN LEU GLU LEU PRO TYR THR PHE GLY SEQRES 9 L 219 GLY GLY THR LYS VAL GLU ILE LYS ARG THR VAL ALA ALA SEQRES 10 L 219 PRO SER VAL PHE ILE PHE PRO PRO SER ASP GLU GLN LEU SEQRES 11 L 219 LYS SER GLY THR ALA SER VAL VAL CYS LEU LEU ASN ASN SEQRES 12 L 219 PHE TYR PRO ARG GLU ALA LYS VAL GLN TRP LYS VAL ASP SEQRES 13 L 219 ASN ALA LEU GLN SER GLY ASN SER GLN GLU SER VAL THR SEQRES 14 L 219 GLU GLN ASP SER LYS ASP SER THR TYR SER LEU SER SER SEQRES 15 L 219 THR LEU THR LEU SER LYS ALA ASP TYR GLU LYS HIS LYS SEQRES 16 L 219 VAL TYR ALA CYS GLU VAL THR HIS GLN GLY LEU SER SER SEQRES 17 L 219 PRO VAL THR LYS SER PHE ASN ARG GLY GLU CYS HELIX 1 AA1 PHE A 45 THR A 51 5 7 HELIX 2 AA2 LEU A 52 MET A 71 1 20 HELIX 3 AA3 PRO A 79 VAL A 84 1 6 HELIX 4 AA4 TRP A 85 ALA A 103 1 19 HELIX 5 AA5 LYS A 110 ILE A 143 1 34 HELIX 6 AA6 LEU A 152 ALA A 157 1 6 HELIX 7 AA7 ASN A 171 ASN A 176 5 6 HELIX 8 AA8 SER A 177 GLY A 210 1 34 HELIX 9 AA9 PHE B 45 THR B 51 5 7 HELIX 10 AB1 LEU B 52 MET B 71 1 20 HELIX 11 AB2 PRO B 79 VAL B 84 1 6 HELIX 12 AB3 TRP B 85 LEU B 100 1 16 HELIX 13 AB4 LYS B 110 ILE B 143 1 34 HELIX 14 AB5 LEU B 152 ALA B 157 1 6 HELIX 15 AB6 ASN B 171 ASN B 176 5 6 HELIX 16 AB7 SER B 177 VAL B 212 1 36 HELIX 17 AB8 ALA H 28 SER H 32 5 5 HELIX 18 AB9 ARG H 87 THR H 91 5 5 HELIX 19 AC1 SER H 162 ALA H 164 5 3 HELIX 20 AC2 SER H 193 LEU H 195 5 3 HELIX 21 AC3 SER L 126 GLY L 133 1 8 HELIX 22 AC4 LYS L 188 LYS L 193 1 6 SHEET 1 AA1 2 GLN H 3 VAL H 5 0 SHEET 2 AA1 2 LYS H 23 SER H 25 -1 O LYS H 23 N VAL H 5 SHEET 1 AA2 6 VAL H 11 LYS H 12 0 SHEET 2 AA2 6 THR H 113 VAL H 117 1 O THR H 116 N LYS H 12 SHEET 3 AA2 6 ALA H 92 ARG H 98 -1 N ALA H 92 O VAL H 115 SHEET 4 AA2 6 ILE H 34 GLN H 39 -1 N VAL H 37 O TYR H 95 SHEET 5 AA2 6 LEU H 45 ILE H 51 -1 O ILE H 51 N ILE H 34 SHEET 6 AA2 6 THR H 58 TYR H 60 -1 O ASP H 59 N ARG H 50 SHEET 1 AA3 3 LYS H 19 SER H 21 0 SHEET 2 AA3 3 THR H 78 GLU H 82 -1 O MET H 81 N VAL H 20 SHEET 3 AA3 3 THR H 69 ASP H 73 -1 N ASP H 73 O THR H 78 SHEET 1 AA4 4 SER H 126 LEU H 130 0 SHEET 2 AA4 4 THR H 141 TYR H 151 -1 O LYS H 149 N SER H 126 SHEET 3 AA4 4 TYR H 182 PRO H 191 -1 O TYR H 182 N TYR H 151 SHEET 4 AA4 4 VAL H 169 THR H 171 -1 N HIS H 170 O VAL H 187 SHEET 1 AA5 3 THR H 157 TRP H 160 0 SHEET 2 AA5 3 CYS H 202 HIS H 206 -1 O ASN H 203 N SER H 159 SHEET 3 AA5 3 THR H 211 VAL H 213 -1 N THR H 211 O HIS H 206 SHEET 1 AA6 2 THR L 5 THR L 7 0 SHEET 2 AA6 2 SER L 22 ARG L 24 -1 O SER L 22 N THR L 7 SHEET 1 AA7 6 SER L 10 VAL L 13 0 SHEET 2 AA7 6 THR L 107 ILE L 111 1 O GLU L 110 N VAL L 13 SHEET 3 AA7 6 GLY L 89 GLN L 95 -1 N GLY L 89 O VAL L 109 SHEET 4 AA7 6 TYR L 39 GLN L 43 -1 N TYR L 41 O TYR L 92 SHEET 5 AA7 6 PRO L 49 TYR L 54 -1 O GLN L 50 N LEU L 42 SHEET 6 AA7 6 ASN L 58 LEU L 59 -1 O ASN L 58 N TYR L 54 SHEET 1 AA8 4 SER L 10 VAL L 13 0 SHEET 2 AA8 4 THR L 107 ILE L 111 1 O GLU L 110 N VAL L 13 SHEET 3 AA8 4 GLY L 89 GLN L 95 -1 N GLY L 89 O VAL L 109 SHEET 4 AA8 4 THR L 102 PHE L 103 -1 O THR L 102 N GLN L 95 SHEET 1 AA9 2 SER L 68 GLY L 71 0 SHEET 2 AA9 2 PHE L 76 LYS L 79 -1 O THR L 77 N SER L 70 SHEET 1 AB1 4 VAL L 120 PHE L 123 0 SHEET 2 AB1 4 THR L 134 PHE L 144 -1 O LEU L 140 N PHE L 121 SHEET 3 AB1 4 TYR L 178 SER L 187 -1 O LEU L 186 N ALA L 135 SHEET 4 AB1 4 SER L 164 VAL L 168 -1 N GLN L 165 O THR L 183 SHEET 1 AB2 4 ALA L 158 LEU L 159 0 SHEET 2 AB2 4 LYS L 150 VAL L 155 -1 N VAL L 155 O ALA L 158 SHEET 3 AB2 4 TYR L 197 THR L 202 -1 O ALA L 198 N LYS L 154 SHEET 4 AB2 4 VAL L 210 PHE L 214 -1 O VAL L 210 N VAL L 201 SSBOND 1 CYS A 167 CYS A 183 1555 1555 2.03 SSBOND 2 CYS B 167 CYS B 183 1555 1555 2.03 SSBOND 3 CYS H 22 CYS H 96 1555 1555 2.03 SSBOND 4 CYS H 146 CYS H 202 1555 1555 2.04 SSBOND 5 CYS L 23 CYS L 93 1555 1555 2.03 SSBOND 6 CYS L 139 CYS L 199 1555 1555 2.04 CISPEP 1 PHE H 152 PRO H 153 0 -4.96 CISPEP 2 GLU H 154 PRO H 155 0 -2.81 CISPEP 3 THR L 7 PRO L 8 0 -1.95 CISPEP 4 LEU L 99 PRO L 100 0 -2.07 CISPEP 5 TYR L 145 PRO L 146 0 3.21 CRYST1 1.000 1.000 1.000 90.00 90.00 90.00 P 1 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 1.000000 0.000000 0.000000 0.00000 SCALE2 0.000000 1.000000 0.000000 0.00000 SCALE3 0.000000 0.000000 1.000000 0.00000